פירדפסה 이스라엘 - 히브리어 - Ministry of Health

פירדפסה

medison pharma ltd - amifampridine - טבליה - amifampridine 10 mg - amifampridine

קלפרופן 10% וטרינרי 이스라엘 - 히브리어 - Ministry of Health

קלפרופן 10% וטרינרי

romat ltd - ketoprofen - תמיסה להזרקה - ketoprofen 100 mg / 1 ml

ברבקטו 1000 מג טבליות לעיסות וטרינרי 이스라엘 - 히브리어 - Ministry of Health

ברבקטו 1000 מג טבליות לעיסות וטרינרי

intervet ( israel) ltd - fluralaner - טבליות לעיסות - fluralaner 1000 mg

ברבקטו 112.5 מג טבליות לעיסות וטרינרי 이스라엘 - 히브리어 - Ministry of Health

ברבקטו 112.5 מג טבליות לעיסות וטרינרי

intervet ( israel) ltd - fluralaner - טבליות לעיסות - fluralaner 112.5 mg

ברבקטו 1400 מג טבליות לעיסות וטרינרי 이스라엘 - 히브리어 - Ministry of Health

ברבקטו 1400 מג טבליות לעיסות וטרינרי

intervet ( israel) ltd - fluralaner - טבליות לעיסות - fluralaner 1400 mg

ברבקטו 250 מג טבליות לעיסות וטרינרי 이스라엘 - 히브리어 - Ministry of Health

ברבקטו 250 מג טבליות לעיסות וטרינרי

intervet ( israel) ltd - fluralaner - טבליות לעיסות - fluralaner 250 mg

ברבקטו 500 מג  טבליות לעיסות וטרינרי 이스라엘 - 히브리어 - Ministry of Health

ברבקטו 500 מג טבליות לעיסות וטרינרי

intervet ( israel) ltd - fluralaner - טבליות לעיסות - fluralaner 500 mg

סנדוסטטין   0.1 מגמל 이스라엘 - 히브리어 - Ministry of Health

סנדוסטטין 0.1 מגמל

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

סנדוסטטין   0.05 מגמל 이스라엘 - 히브리어 - Ministry of Health

סנדוסטטין 0.05 מגמל

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.